BFC Planning’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
BFC Planning's CGON Position: Q3 2026 in Review
BFC Planning held its CG Oncology (CGON) position steady in Q3 2026 at 8 shares worth $567. The position accounts for ﹤0.01% of the portfolio, ranked #3274.
BFC Planning first reported a position in CGON in Q4 2025 and has held it in 4 quarters since. The position peaked at $568 in Q2 2026. 165 funds tracked by Wall St. Rank hold CGON as of Q3 2026.
- BFC Planning held 8 shares of CG Oncology worth $567 as of Q3 2026.
- BFC Planning left its CG Oncology share count unchanged in Q3 2026.
- CG Oncology made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3274 holding.
- BFC Planning first reported a position in CG Oncology in Q4 2025 and has held it in 4 quarters since.
- BFC Planning's CG Oncology position peaked at $568 in Q2 2026.
- 165 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.